Poor aqueous solubility of carbamazepine (API) is a persistent problem since many years. This issue is prominently relevant to Biopharmaceutics Classification System (BCS) Class II and Class IV drugs. Currently we are working to resolve this issue by using the complexation approach using a novel source Fulvic acid. Although FA has been used for solubility enhancement, but our novel sourced fulvic acid which is purer, cheaper and low on contaminants is yet to be exploited as a pharmaceutical excipient with improved functionality. So , the novelty of this idea relies in the fact that our novel sourced fulvic acid is explored for its pharmaceutical potential. Further the our developed complex is characterized physically on the basis of DSC, FTIR and XRD studies with the pure drug and complexed drug. The results are outstanding! Authored by: Rahmuddin Khan Dept. of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi...